{"cik":"0001094038","ticker":"MRKR","name":"Marker Therapeutics, Inc.","sic_code":"2834","sic_description":"Pharmaceutical Preparations","exchange":"Nasdaq","state_of_incorporation":"DE","fiscal_year_end":"1231","first_filing_date":"2026-05-15","last_filing_date":"2026-05-15","url":"/sec/cik-0001094038","insider_summary":{"total_transactions":0,"unique_insiders":0,"latest_transaction":null},"recent_filings":[{"accession_number":"0001104659-26-062763","form_type":"10-Q","form_type_family":"quarterly","doc_date":"2026-05-15","title":"10-Q — Marker Therapeutics, Inc. — 2026-05-15","url_slug":"/sec/cik-0001094038/10-q/0001104659-26-062763","edgar_url":"https://www.sec.gov/Archives/edgar/data/1094038/0001104659-26-062763-index.html"}],"related_endpoints":{"profile":"/sec/MRKR/profile","timeline":"/sec/MRKR/timeline","peers":"/sec/MRKR/peers","insider_pulse":"/sec/MRKR/insider-pulse","insider_summary":"/sec/MRKR/insider-summary","insider_transactions":"/sec/MRKR/insider-transactions","form144":"/sec/MRKR/form144","holdings_as_filer":"/sec/MRKR/holdings","financial_facts":"/sec/MRKR/financial-facts","derivatives":"/sec/MRKR/derivatives","officers":"/sec/MRKR/officers","insider_network":"/sec/MRKR/insider-network","risk_flags":"/sec/MRKR/risk-flags","filings":"/sec/MRKR/filings","cross_topic_dossier":"/api/v1/dossier?ticker=MRKR"}}